Search

1. Assessing user fees under the Prescription Drug User Fee Amendments of 2017

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Fees and Charges
Investigational New Drug Application -- economics
Prescription Drugs -- economics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. Searching for savings in Medicare drug price negotiations

Author(s):

Cubanski, Juliette, author
Neuman, Tricia, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, April 2018

Subject(s):

Drug Costs
Medicare Part D -- economics
Negotiating
Prescription Drugs -- economics
United States

3. How does the Trump Administration drug pricing blueprint affect Medicaid?

Author(s):

Young, Katherine, author

Publication:

San Francisco, CA : Henry J. Kaiser Family Foundation, May 2018

Subject(s):

Cost Control
Drug Costs
Medicaid -- economics
Prescription Drugs -- economics
United States
United States.

4. The Medi-Cal prescription drug benefit: an overview

Publication:

Oakland, Calif. : California HealthCare Foundation, [2009]

Subject(s):

Health Expenditures -- trends
Insurance Benefits
Insurance, Pharmaceutical Services
Medicaid
Prescription Drugs -- economics
California

5. Prescription drug spending by Medicare beneficiaries in institutional and residential settings, 1998-2001

Author(s):

Simoni-Wastila, Linda, author
Stuart, Bruce C., author
Shaffer, Thomas, author

Publication:

Washington, D.C. : Office of Disability, Aging, and Long-Term Care Policy, Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, [2007]

Subject(s):

Prescription Drugs -- economics
Prescription Fees -- statistics & numerical data
Aged
Assisted Living Facilities
Health Expenditures -- statistics & numerical data
Medicare Part D -- statistics & numerical data
United States

6. Getting to the root of high prescription drug prices: drivers and potential solutions

Author(s):

Waxman, Henry, author
Corr, Bill, author
Martin, Kristi, author
Duong, Sophia, author

Publication:

[New York, N.Y.] : Commonwealth Fund, July 2017

Subject(s):

Cost Control
Drug Costs
Health Policy
Prescription Drugs -- economics
United States

7. Medicaid's most costly outpatient drugs

Author(s):

Young, Katherine, author
Rudowitz, Robin, author
Garfield, Rachel, author
Musumeci, MaryBeth, author

Publication:

Menlo Park, CA : Henry J. Kaiser Family Foundation, July 2016

Subject(s):

Drug Costs -- statistics & numerical data
Economics, Pharmaceutical
Medicaid -- economics
Prescription Drugs -- economics
United States

8. Price decreases for widely used generic drugs slow in 2017 after two years of substantial price drops

Author(s):

Schondelmeyer, Stephen W., author
Purvis, Leigh, author

Publication:

Washington, DC : AARP Public Policy Institute, April 2019

Subject(s):

Drug Costs -- trends
Drugs, Generic -- economics
Prescription Drugs -- economics
United States

9. Trends in retail prices of generic prescription drugs widely used by older Americans: 2017 year-end update

Author(s):

Schondelmeyer, Stephen W., author
Purvis, Leigh, author

Publication:

Washington, DC : AARP Public Policy Institute, April 2019

Subject(s):

Drug Costs -- trends
Drugs, Generic -- economics
Prescription Drugs -- economics
United States

10. Brand name prescription drug prices increase four times faster than inflation in 2017

Author(s):

Schondelmeyer, Stephen W., author
Purvis, Leigh, author

Publication:

Washington, DC : AARP Public Policy Institute, September 2018

Subject(s):

Drug Costs -- trends
Prescription Drugs -- economics
United States